The Effect of Combination of Mediterranean Diet and Oleocanthal in Patients with Mild Cognitive Impairment
NCT06705738 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2024-11-26
Summary
BACKGROUND: Mild cognitive impairment (MCI) constitutes a form of preclinical dementia and characterizes a cognitive decline that exceeds what is expected for one's age and education status, but at the same time does not fulfill the criteria for dementia. MCI is considered a prodromal stage of Alzheimer's disease (AD) and the progression to this neurodegenerative disease, renders the patients heavily dependent on their relatives and the society, which creates a huge psychological and financial burden, since no effective treatment exists for MCI and AD to this day. Mediterranean diet (MeDi) displays beneficial effects on the cognitive function of both healthy individuals and cognitive impaired patients. High Phenolic Early Harvest Extra Virgin Olive Oil (HP-EH-EVOO) is a natural product that contains high concentrations of the substance Oleocanthal (OLC), while at the same time it has been shown to exert beneficial properties on the cognitive function of cognitive impaired individuals, as well as on the slowing down of the decline of cognitive function.
AIM: The main hypothesis that will be evaluated is whether the combined approach of the MeDi pattern and the concurrent intervention with the administration in a capsule form of the supplement containing olive oil polyphenols with the main substance being Oleocanthal (SUPOL), could constitute a considerable strategy of management of MCI patients.
Study Type: Investigational Study Design, Allocantion: Randomized Intervention Model, Parallel Assignment Masking: Single Blind (Outcome Assessor - Investigator) on Diet, Double Blind (Subject, Outcome Assessor - Investigator) on Supplement, Primary Purpose: Prevention.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
SUPOL
Supplement containing Olive Oil Polyphenol with the main substance being Oleocanthal (SUPOL), 2 capsules twice a day (4 capsules total) for 12 months.
- OTHER
-
Dietary Pattern: MeDi
Adherance to Mediterranean dietary pattern to be followed for 12 months.
Sponsors & Collaborators
-
Greek Alzheimer's Association and Related Disorders
collaborator OTHER -
University of Glasgow
collaborator OTHER -
World Olive Center for Health
collaborator UNKNOWN -
Aristotle University Of Thessaloniki
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 60 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-11-01
- Primary Completion
- 2026-04-30
- Completion
- 2026-11-01
Countries
- Greece
Study Locations
More Related Trials
-
Trial of a Brain Preservation Diet in Preventing Cognitive Decline in Old Age Hostel Residents
NCT01132261 ·Status: COMPLETED ·Phase: NA
-
Nutrition-based Interventions to Prevent Cognitive Decline
NCT06853405 ·Status: RECRUITING ·Phase: NA
-
Imagery in Early Stages of Dementia
NCT05232526 ·Status: UNKNOWN ·Phase: NA
-
Environmental Design for Behavioral Regulation in People With Dementia
NCT04555616 ·Status: COMPLETED ·Phase: NA
-
Dietary Adherence and Cognitive Function in Older Adults
NCT06631027 ·Status: COMPLETED
-
Positive Psychology for Early Cognitive Decline: Effects on Cognitive and Brain Function
NCT07289061 ·Status: RECRUITING ·Phase: NA
-
Conversations as a Means to Delay the Onset of Alzheimer's Disease
NCT01571427 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Pilot Mobile for Dementia and Frailty
NCT05827094 ·Status: COMPLETED ·Phase: NA
-
Acceptability of Products and Eating Pleasure in Elderly People Living at Home or in Establishment Hosting For the Dependant Elderly (EHPAD) (Old-people's Home)
NCT02873897 ·Status: UNKNOWN ·Phase: NA
-
Alzheimer's Disease, Art and Garden
NCT02208193 ·Status: UNKNOWN ·Phase: NA
-
Contribution of Physical Activity to Self-esteem and Motivation in Older Adults With Minor to Major Cognitive Disorders Such as Alzheimer's Disease or Related Disorders
NCT03866018 ·Status: UNKNOWN ·Phase: NA
-
OTC Hearing Aid and MCI
NCT06112860 ·Status: RECRUITING ·Phase: NA
-
UK Based Remote Brain Health Clinic (BHC) for Patients With Mild Cognitive Impairment (MCI)
NCT06379594 ·Status: ENROLLING_BY_INVITATION
-
Effect of Individual Reminiscence Therapy in the Elderly People With Neurocognitive Disorders
NCT04658394 ·Status: COMPLETED ·Phase: NA
-
Predicting the Conversion From Mild Cognitive Impairment to Dementia
NCT01823666 ·Status: COMPLETED
-
Evaluation of a Diet in Patients With Senile Dementia
NCT01192529 ·Status: UNKNOWN ·Phase: NA
-
Remote Ischemic Conditioning of the Human Brain in Dementia Patients
NCT04168021 ·Status: UNKNOWN ·Phase: NA
-
Meaningful Aspects of Health for Adults With Dementia, Their Care Partners and Healthcare Practitioners
NCT06242574 ·Status: WITHDRAWN
-
PRedicting the EVolution of SubjectIvE Cognitive Decline to Alzheimer's Disease With Machine Learning
NCT05569083 ·Status: UNKNOWN
-
Effects of Light-therapy in Alzheimer's Disease
NCT02686190 ·Status: COMPLETED ·Phase: NA
-
Depression, Anxiety and Social Relationships as Risk Factors for Dementia
NCT04786561 ·Status: COMPLETED
-
Effectiveness of the Nordic Sensi Chair in the Treatment of Dementia Behavioral Disorders (NSC-DEMEN)
NCT05706792 ·Status: COMPLETED ·Phase: NA
-
The Effect of Person-Centered Care Applied to Patients With Dementia on Nutritional Status
NCT06191172 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Brain-Health Lifestyle Restructuring Intervention
NCT04576624 ·Status: UNKNOWN ·Phase: NA
-
Alzheimer's Disease and Related Disorders
NCT01315704 ·Status: UNKNOWN